BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Boston Children's Hospital · Harvard Stem Cell Institute · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
908
total citations
- FWCI
- 43.52
- Percentile
- 100%
- References
- 66
Citations per year
Authors
19- MCMatthew C. CanverCorresponding
Boston Children's Hospital, Harvard Stem Cell Institute, Harvard University, Dana-Farber Cancer Institute
- ECElenoe C. Smith
Harvard University, Boston Children's Hospital, Harvard Stem Cell Institute, Dana-Farber Cancer Institute
- FSFalak Sher
Harvard University, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Boston Children's Hospital
- LPLuca Pinello
Dana-Farber Cancer Institute
- NENeville E. Sanjana
Topics & keywords
Topics
Keywords
- Enhancer
- CRISPR
- Biology
- Cas9
- Enhancer RNAs
- Computational biology
- Mutagenesis
- Genome editing
No related works found for this paper.